Berthold F - Search Results

1

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients.

Zeka F, Decock A, Van Goethem A, Vanderheyden K, Demuynck F, Lammens T, Helsmoortel HH, Vermeulen J, Noguera R, Berbegall AP, Combaret V, Schleiermacher G, Laureys G, Schramm A, Schulte JH, Rahmann S, Bienertová-Vašků J, Mazánek P, Jeison M, Ash S, Hogarty MD, Moreno-Smith M, Barbieri E, Shohet J, Berthold F, Van Maerken T, Speleman F, Fischer M, De Preter K, Mestdagh P, Vandesompele J. Zeka F, et al. Among authors: berthold f. JCI Insight. 2018 Dec 6;3(23):e97021. doi: 10.1172/jci.insight.97021. JCI Insight. 2018. PMID: 30518699 Free PMC article.

2

Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.

Berthold F, Hunneman DH, Harms D, Käser H, Zieschang J. Berthold F, et al. Eur J Cancer. 1992;28A(12):1950-4. doi: 10.1016/0959-8049(92)90234-s. Eur J Cancer. 1992. PMID: 1419287

3

Plasma neurotensin: lack of a differentiation and tumor marker in children with neuroblastoma.

Becker K, Berthold F. Becker K, et al. Among authors: berthold f. Pediatr Hematol Oncol. 1992 Jul-Sep;9(3):269-72. doi: 10.3109/08880019209016595. Pediatr Hematol Oncol. 1992. PMID: 1525006

4

Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.

Klingebiel T, Berthold F, Treuner J, Schwabe D, Fischer M, Feine U, Maul FD, Waters W, Wehinger H, Niethammer D. Klingebiel T, et al. Among authors: berthold f. Med Pediatr Oncol. 1991;19(2):84-8. doi: 10.1002/mpo.2950190203. Med Pediatr Oncol. 1991. PMID: 2011100

5

[131(I)-meta-iodobenzylguanidine treatment of 32 children with therapy-refractory neuroblastoma].

Berthold F, Feine U, Fischer M, Gerein V, Klingebiel T, Maul FD, Waters W, Wehinger H, Treuner J. Berthold F, et al. Klin Padiatr. 1988 May-Jun;200(3):226-9. doi: 10.1055/s-2008-1033713. Klin Padiatr. 1988. PMID: 3062260 German.

6

The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.

Gehring M, Berthold F, Edler L, Schwab M, Amler LC. Gehring M, et al. Among authors: berthold f. Cancer Res. 1995 Nov 15;55(22):5366-9. Cancer Res. 1995. PMID: 7585602

7

Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse model.

Gottstein C, Schön G, Tawadros S, Kube D, Wargalla-Plate UC, Hansmann ML, Wacker HH, Berthold F, Diehl V, Engert A. Gottstein C, et al. Among authors: berthold f. Cancer Res. 1994 Dec 1;54(23):6186-93. Cancer Res. 1994. PMID: 7954465

8

Multivariate evaluation of prognostic factors in localized neuroblastoma.

Berthold F, Kassenböhmer R, Zieschang J. Berthold F, et al. Am J Pediatr Hematol Oncol. 1994 May;16(2):107-15. Am J Pediatr Hematol Oncol. 1994. PMID: 8166363

9

Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group.

Favrot MC, Ambros P, Schilling F, Frappaz D, Combaret V, Berthold F, Dominici C, Erttmann R, Esteve J, Jenkner A, Kerbl R, Mann J, Mathieu P, Parker L, Powell J, Philip T. Favrot MC, et al. Among authors: berthold f. Ann Oncol. 1996 Aug;7(6):607-11. doi: 10.1093/oxfordjournals.annonc.a010678. Ann Oncol. 1996. PMID: 8879375 Free article. Review.

10

Testicular and paratesticular involvement by metastatic neuroblastoma.

Simon T, Hero B, Berthold F. Simon T, et al. Among authors: berthold f. Cancer. 2000 Jun 1;88(11):2636-41. doi: 10.1002/1097-0142(20000601)88:11<2636::aid-cncr28>3.0.co;2-k. Cancer. 2000. PMID: 10861443 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

346 results

Search Page